Edition:
United States

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,204.00GBp
27 Feb 2017
Change (% chg)

-2.00 (-0.17%)
Prev Close
1,206.00
Open
1,196.00
Day's High
1,204.00
Day's Low
1,195.00
Volume
393,790
Avg. Vol
3,332,302
52-wk High
1,324.00
52-wk Low
1,064.91

Select another date:

Wed, Feb 22 2017

BRIEF-Smith & Nephew signs agreement to distribute Leaf Healthcare technology

* Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure injury technology Source text for Eikon: Further company coverage:

Smith & Nephew hurt by tough markets in China, Gulf states

LONDON Smith & Nephew , Europe's biggest artificial hip and knee maker, reported a 7 percent drop in full-year trading profit, missing average analysts' forecasts, as tough market conditions in China and Saudi Arabia kept growth in check.

UPDATE 2-Smith & Nephew hurt by tough markets in China and Gulf states

* Shares down 2.4 pct (Adds CEO comments, further analyst reaction, updates shares)

Falls in Smith & Nephew, miners weigh on Britain's FTSE

LONDON, Feb 9 Britain's top share index steadied on Thursday as falls among mining stocks weighed, while Smith & Nephew dropped after posting disappointing results.

Smith & Nephew hit by tough markets in China, Gulf States

LONDON, Feb 9 Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 7 percent drop in full-year trading profit, missing average forecasts, as tough market conditions in China and the Gulf States kept growth in check.

UPDATE 1-Smith & Nephew revenue up 2 pct, at bottom end of forecasts

LONDON, Nov 3 Artificial hip and knee maker Smith & Nephew reported a 2 percent rise in underlying quarterly revenue to $1.12 billion, towards the bottom of forecasts, after sales grew only 2 percent in the United States and stalled in other established markets.

Smith & Nephew Q3 revenue rise at bottom-end of forecasts

LONDON, Nov 3 Artificial hip and knee maker Smith & Nephew reported a 2 percent rise in third-quarter revenue to $1.12 billion, towards the bottom of expectations, as sales grew only 2 percent in the United States and stalled in other established markets.

Select another date:

More From Around the Web